Jia Guo1, Samantha J Holdsworth1, Audrey P Fan1, Marc R Lebel2, Zungho Zun3,4, Ajit Shankaranarayanan5, Greg Zaharchuk1. 1. Department of Radiology, Stanford University, Stanford, California, USA. 2. GE Healthcare, Calgary, Canada. 3. Diagnostic Imaging and Radiology, Children's National Medical Center, Washington, DC, USA. 4. Department of Pediatrics, George Washington University, Washington, DC, USA. 5. GE Healthcare, Menlo Park, California, USA.
Abstract
PURPOSE: To compare performance of sequential and Hadamard-encoded pseudocontinuous arterial spin labeling (PCASL). MATERIALS AND METHODS: Monte Carlo simulations and in vivo experiments were performed in 10 healthy subjects. Field strength and sequence: 5-delay sequential (5-del. Seq.), 7-delay Hadamard-encoded (7-del. Had.), and a single-delay (1-del.) PCASL, without and with vascular crushing at 3.0T. The errors and variations of cerebral blood flow (CBF) and arterial transit time (ATT) from simulations and the CBF and ATT estimates and variations in gray matter (GM) with different ATT ranges were compared. Pairwise t-tests with Bonferroni correction were used. RESULTS: The simulations and in vivo experiments showed that 1-del. PCASL underestimated GM CBF due to insufficient postlabeling delay (PLD) (37.2 ± 8.1 vs. 47.3 ± 8.5 and 47.3 ± 9.0 ml/100g/min, P ≤ 6.5 × 10-6 ), while 5-del. Seq. and 7-del. Had. yielded comparable GM CBF (P ≥ 0.49). 5-del. Seq. was more reproducible for CBF (P = 4.7 × 10-4 ), while 7-del. Had. was more reproducible for ATT (P = 0.033). 5-del. Seq. was more prone to intravascular artifacts and yielded lower GM ATTs compared to 7-del. Had. without crushing (1.13 ± 0.18 vs. 1.23 ± 0.13 seconds, P = 2.3 × 10-3 ), but they gave comparable ATTs with crushing (P = 0.12). ATTs measured with crushing were longer than those without crushing (P ≤ 6.7 × 10-4 ), but CBF was not affected (P ≥ 0.16). CONCLUSION: The theoretical signal-to-noise ratio (SNR) gain through Hadamard encoding was confirmed experimentally. For 1-del., a PLD of 1.8 seconds is recommended for healthy subjects. With current parameters, 5-del. Seq. was more reproducible for CBF, and 7-del. Had. for ATT. Vascular crushing may help reduce variations in multidelay experiments without compromising tissue CBF or ATT measurements. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1119-1132.
PURPOSE: To compare performance of sequential and Hadamard-encoded pseudocontinuous arterial spin labeling (PCASL). MATERIALS AND METHODS: Monte Carlo simulations and in vivo experiments were performed in 10 healthy subjects. Field strength and sequence: 5-delay sequential (5-del. Seq.), 7-delay Hadamard-encoded (7-del. Had.), and a single-delay (1-del.) PCASL, without and with vascular crushing at 3.0T. The errors and variations of cerebral blood flow (CBF) and arterial transit time (ATT) from simulations and the CBF and ATT estimates and variations in gray matter (GM) with different ATT ranges were compared. Pairwise t-tests with Bonferroni correction were used. RESULTS: The simulations and in vivo experiments showed that 1-del. PCASL underestimated GM CBF due to insufficient postlabeling delay (PLD) (37.2 ± 8.1 vs. 47.3 ± 8.5 and 47.3 ± 9.0 ml/100g/min, P ≤ 6.5 × 10-6 ), while 5-del. Seq. and 7-del. Had. yielded comparable GM CBF (P ≥ 0.49). 5-del. Seq. was more reproducible for CBF (P = 4.7 × 10-4 ), while 7-del. Had. was more reproducible for ATT (P = 0.033). 5-del. Seq. was more prone to intravascular artifacts and yielded lower GM ATTs compared to 7-del. Had. without crushing (1.13 ± 0.18 vs. 1.23 ± 0.13 seconds, P = 2.3 × 10-3 ), but they gave comparable ATTs with crushing (P = 0.12). ATTs measured with crushing were longer than those without crushing (P ≤ 6.7 × 10-4 ), but CBF was not affected (P ≥ 0.16). CONCLUSION: The theoretical signal-to-noise ratio (SNR) gain through Hadamard encoding was confirmed experimentally. For 1-del., a PLD of 1.8 seconds is recommended for healthy subjects. With current parameters, 5-del. Seq. was more reproducible for CBF, and 7-del. Had. for ATT. Vascular crushing may help reduce variations in multidelay experiments without compromising tissue CBF or ATT measurements. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1119-1132.
Authors: Michael A Chappell; Bradley J MacIntosh; Manus J Donahue; Matthias Günther; Peter Jezzard; Mark W Woolrich Journal: Magn Reson Med Date: 2010-05 Impact factor: 4.668
Authors: K K Kwong; J W Belliveau; D A Chesler; I E Goldberg; R M Weisskoff; B P Poncelet; D N Kennedy; B E Hoppel; M S Cohen; R Turner Journal: Proc Natl Acad Sci U S A Date: 1992-06-15 Impact factor: 11.205
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Martine Elbejjani; Reto Auer; Sudipto Dolui; David R Jacobs; Thaddeus Haight; David C Goff; John A Detre; Christos Davatzikos; R Nick Bryan; Lenore J Launer Journal: J Cereb Blood Flow Metab Date: 2018-01-22 Impact factor: 6.200
Authors: Pan Su; Hongli Fan; Peiying Liu; Yang Li; Ye Qiao; Jun Hua; Doris Lin; Dengrong Jiang; Jay J Pillai; Argye E Hillis; Hanzhang Lu Journal: NMR Biomed Date: 2019-11-04 Impact factor: 4.044
Authors: Briana P Meyer; Lydiane Hirschler; Seongtaek Lee; Shekar N Kurpad; Jan M Warnking; Emmanuel L Barbier; Matthew D Budde Journal: J Cereb Blood Flow Metab Date: 2021-01-28 Impact factor: 6.200
Authors: Moss Y Zhao; Audrey P Fan; David Yen-Ting Chen; Magdalena J Sokolska; Jia Guo; Yosuke Ishii; David D Shin; Mohammad Mehdi Khalighi; Dawn Holley; Kim Halbert; Andrea Otte; Brittney Williams; Taghi Rostami; Jun-Hyung Park; Bin Shen; Greg Zaharchuk Journal: Neuroimage Date: 2021-03-11 Impact factor: 6.556
Authors: K Setta; T Matsuda; M Sasaki; T Chiba; S Fujiwara; M Kobayashi; K Yoshida; Y Kubo; M Suzuki; K Yoshioka; K Ogasawara Journal: AJNR Am J Neuroradiol Date: 2021-05-20 Impact factor: 4.966
Authors: Tracy Ssali; Udunna C Anazodo; Lucas Narciso; Linshan Liu; Sarah Jesso; Lauryn Richardson; Matthias Günther; Simon Konstandin; Klaus Eickel; Frank Prato; Elizabeth Finger; Keith St Lawrence Journal: Neuroimage Clin Date: 2021-10-07 Impact factor: 4.891